Walleye Trading’s Roivant Sciences ROIV Stock Holding History

Walleye Trading’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.4K	Sell	700 -60,200	-99%	-$1.55M	﹤0.01%	3870
2025 Q4	$1.32M	Sell	60,900 -6,400	-10%	-$126K	﹤0.01%	2176
2025 Q3	$1.02M	Buy	67,300 +23,200	+53%	+$287K	﹤0.01%	2256
2025 Q2	$497K	Buy	44,100 +8,500	+24%	+$92.1K	﹤0.01%	2657
2025 Q1	$359K	Hold	35,600	–	–	﹤0.01%	2738
2024 Q4	$421K	Sell	35,600 -3,600	-9%	-$42.6K	﹤0.01%	2738
2024 Q3	$452K	Buy	39,200 +4,200	+12%	+$47.8K	﹤0.01%	2576
2024 Q2	$370K	Buy	+35,000	New	+$384K	﹤0.01%	2726
2024 Q1	–	Sell	-300	Closed	-$3.37K	–	5248
2023 Q4	$3.37K	Buy	+300	New	+$2.92K	﹤0.01%	4755

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Trading's ROIV Position: Q1 2026 in Review

Walleye Trading opened a new position in Roivant Sciences (ROIV) in Q1 2026: 3,420 shares worth $94.7K. The stake represents ﹤0.01% of the portfolio and ranks #3478 among its holdings. This is a return to the name: Walleye Trading previously reported a position in ROIV as recently as Q4 2023.

Walleye Trading first reported a position in ROIV in Q4 2023 and has held it in 2 quarters since. The position peaked at $446K in Q4 2023. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Walleye Trading held 3,420 shares of Roivant Sciences worth $94.7K as of Q1 2026.
Roivant Sciences was a new Walleye Trading position in Q1 2026.
Roivant Sciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3478 holding.
Walleye Trading first reported a position in Roivant Sciences in Q4 2023 and has held it in 2 quarters since.
Walleye Trading's Roivant Sciences position peaked at $446K in Q4 2023.
439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.